Evidence Level
Green Tea Extract is a well-researched botanical supplement with demonstrated benefits for inflammation, metabolism, and body composition. A systematic review by Haghighatdoost and Hariri (2019) identified that epigallocatechin gallate (EGCG), a key polyphenol in green tea extract, exhibits anti-inflammatory effects by inhibiting nuclear factor-kappa B (NF-kB) and cyclooxygenase-2 (COX-2) while activating Nrf2 antioxidant pathways. Recent evidence from Asbaghi et al. (2024) highlights that green tea extract supplementation significantly reduces body mass, body fat percentage, and BMI in overweight individuals, while also enhancing antioxidant capacity and adiponectin levels.
A meta-analysis by Lin et al. (2020) confirmed the metabolic benefits of green tea extract, showing significant reductions in body weight (-1.78 kg, p=.001) and BMI (-0.65 kg/m², p=.001) among obese individuals. Additionally, Asbaghi et al. (2020) found that higher doses of green tea extract (>800 mg/day) over longer durations (>8 weeks) effectively lowered triglyceride levels in type 2 diabetes patients. However, findings on insulin sensitivity were less consistent across studies, as noted by Wang et al. (2014).
Safety considerations are important, with the European Food Safety Authority (EFSA, 2018) recommending a maximum daily intake of 800 mg EGCG, particularly when consumed with food to mitigate hepatotoxicity risks. Overall, green tea extract exhibits promising effects supported by rigorous clinical trials and systematic reviews.